Targeting the Electron Transport System for Enhanced Longevity
Biomolecules · 2025
DOI: 10.3390/biom15050614 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Marko Radovic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacology, Section of Experimental Pharmacology, University Medical Center Groningen, University of Groningen,…. Hauptthemen laut MEDLINE: Longevity. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Kidney Foundation, Graduate School of Medical Sciences, University of Groningen, Graduate School for Medical Sciences, University of Groningen.
Abstract (Originalsprache)
Damage to mitochondrial DNA (mtDNA) results in defective electron transport system (ETS) complexes, initiating a cycle of impaired oxidative phosphorylation (OXPHOS), increased reactive oxygen species (ROS) production, and chronic low-grade inflammation (inflammaging). This culminates in energy failure, cellular senescence, and progressive tissue degeneration. Rapamycin and metformin are the most extensively studied longevity drugs. Rapamycin inhibits mTORC1, promoting mitophagy, enhancing mitochondrial biogenesis, and reducing inflammation. Metformin partially inhibits Complex I, lowering reverse electron transfer (RET)-induced ROS formation and activating AMPK to stimulate autophagy and mitochondrial turnover. Both compounds mimic caloric restriction, shift metabolism toward a catabolic state, and confer preclinical—and, in the case of metformin, clinical—longevity benefits. More recently, small molecules directly targeting mitochondrial membranes and ETS components have emerged. Compounds such as Elamipretide, Sonlicromanol, SUL-138, and others modulate metabolism and mitochondrial function while exhibiting similarities to metformin and rapamycin, highlighting their potential in promoting longevity. The key question moving forward is whether these interventions should be applied chronically to sustain mitochondrial health or intermittently during episodes of stress. A pragmatic strategy may combine chronic metformin use with targeted mitochondrial therapies during acute physiological stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Pharmacology, Section of Experimental Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1 (AP50), 9713 GZ Groningen, The Netherlands.
ORCID-Profile: Marko Radovic, Lucas P Gartzke, Simon E Wink, Frouwkje A Politiek, Guido Krenning
Förderung
- Dutch Kidney Foundation
- Graduate School of Medical Sciences, University of Groningen
- Graduate School for Medical Sciences, University of Groningen
Zitieren
APA
Radovic, M., Gartzke, L. P., Wink, S. E., van der Kleij, J. A., Politiek, F. A., & Krenning, G. (2025). Targeting the Electron Transport System for Enhanced Longevity. Biomolecules. https://doi.org/10.3390/biom15050614
Vancouver
Radovic M, Gartzke LP, Wink SE, van der Kleij JA, Politiek FA, Krenning G. Targeting the Electron Transport System for Enhanced Longevity. Biomolecules. 2025. doi:10.3390/biom15050614
BibTeX
@article{Radovic2025,
author = {Radovic, Marko and Gartzke, Lucas P and Wink, Simon E and van der Kleij, Joris A and Politiek, Frouwkje A and Krenning, Guido},
title = {Targeting the Electron Transport System for Enhanced Longevity},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15050614}
}
EUVIMED